Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry ; volume:12 ; number:1 ; day:10 ; month:2 ; year:2012 ; pages:1-10 ; date:12.2012
BMC public health ; 12, Heft 1 (10.2.2012), 1-10, 12.2012
- Creator
-
Pavlík, Tomáš
- Contributor
-
Majek, Ondrej
Mužík, Jan
Koptíková, Jana
Slavíček, Lubomír
Finek, Jindrich
Feltl, David
Vyzula, Rostislav
Dusek, Ladislav
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-12-117
- URN
-
urn:nbn:de:1111-2016081412952
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pavlík, Tomáš
- Majek, Ondrej
- Mužík, Jan
- Koptíková, Jana
- Slavíček, Lubomír
- Finek, Jindrich
- Feltl, David
- Vyzula, Rostislav
- Dusek, Ladislav
- SpringerLink (Online service)
Other Objects (12)
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Acid affairs in anti-tumour immunity
The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models
Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Acid affairs in anti-tumour immunity
The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models
Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
The nuclear factor ID3 endows macrophages with a potent anti-tumour activity
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer
Acid affairs in anti-tumour immunity
The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models
Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody